Polcari Ingrid, Becker Lauren, Stein Sarah L, Smith Marilyn S, Paller Amy S
Department of Dermatology, University of Minnesota, Minneapolis, Minnesota.
Pediatr Dermatol. 2014 Jul-Aug;31(4):489-92. doi: 10.1111/pde.12355. Epub 2014 Jun 12.
Atopic dermatitis (AD) and ichthyosis vulgaris (IV) are two common disorders of epidermal homeostasis resulting in dry skin. The profilaggrin gene, located on chromosome 1q22, encodes a keratin filament aggregating protein (filaggrin) that is essential to forming the epidermal barrier and maintaining hydration. Null mutations in filaggrin have been found to underlie IV and are common in patients with AD, but the minority of African Americans with AD or IV show these mutations in filaggrin. We have selectively studied African Americans with both AD and IV to maximize the possibility of finding filaggrin null mutations in this population. DNA was collected using buccal swabs from 18 African American children with both AD and IV and 17 African American controls without either of these diseases. Purified genomic DNA was amplified using polymerase chain reaction from three regions of the filaggrin gene, exon 3, including R501X, 2282del4, E2554X, R2447X, 1249insG, R826X, 2767insT, and E2422X. Of the African American children with both AD and IV, 22.2% were heterozygous for filaggrin null mutations. Out of the control group, one carried a null mutation and was later discovered to have a history of asthma. Null mutations found in this population included R501X (n = 1), 2282del4 (n = 2), and R826X (n = 2, including the control patient). Our data demonstrate a prevalence of filaggrin mutations in the African American population that exceeds previously published data, although the overall prevalence is still lower than in other populations. It is likely that factors other than known FLG mutations are involved in African American patients.
特应性皮炎(AD)和寻常型鱼鳞病(IV)是导致皮肤干燥的两种常见的表皮稳态疾病。位于1q22染色体上的兜甲蛋白基因编码一种角蛋白丝聚集蛋白(兜甲蛋白),该蛋白对于形成表皮屏障和维持水合作用至关重要。已发现兜甲蛋白的无效突变是IV的基础,并且在AD患者中很常见,但少数患有AD或IV的非裔美国人显示出这些兜甲蛋白突变。我们选择性地研究了患有AD和IV的非裔美国人,以最大限度地提高在该人群中发现兜甲蛋白无效突变的可能性。使用口腔拭子从18名患有AD和IV的非裔美国儿童以及17名没有这两种疾病的非裔美国对照者中收集DNA。使用聚合酶链反应从兜甲蛋白基因的三个区域,即外显子3,包括R501X、2282del4、E2554X、R2447X、1249insG、R826X、2767insT和E2422X,扩增纯化的基因组DNA。在患有AD和IV的非裔美国儿童中,22.2%为兜甲蛋白无效突变的杂合子。在对照组中,有一人携带无效突变,后来发现有哮喘病史。在该人群中发现的无效突变包括R501X(n = 1)、2282del4(n = 2)和R826X(n = 2,包括对照患者)。我们的数据表明,非裔美国人中兜甲蛋白突变的患病率超过了先前公布的数据,尽管总体患病率仍低于其他人群。非裔美国患者可能涉及已知FLG突变以外的因素。